Keith Klein is General Counsel at KYTHERA BIOPHARMACEUTICALS INC (KYTH). They have made 3 open-market trades across 1 company since 2013, most recently 2015-10-01.
CIK 0001559510
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KYTH | 4,068 | — |
Shares reported on the most recent Form 4, priced at the 2015-09-24 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KYTH | SELL | 2015-09-23 | 2015-09-24 | $74.90 | $3.9M | N/A | N/A | N/A |
| KYTH | SELL | 2015-09-22 | 2015-09-23 | $74.90 | $793K | N/A | N/A | N/A |
| KYTH | SELL | 2015-04-30 | 2015-04-30 | $45.52 | $75K | N/A | N/A | N/A |
| KYTH | SELL · 10b5-1 | 2013-09-09 | 2013-09-10 | $32.00 | $144K | N/A | N/A | N/A |
| KYTH | SELL · 10b5-1 | 2013-06-28 | 2013-07-01 | $27.00 | $122K | N/A | N/A | N/A |
| KYTH | SELL · 10b5-1 | 2013-05-01 | 2013-05-03 | $23.63 | $213K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.